Kamkaen N.; Chittasupho C.; Vorarat S.; Tadtong S.; Phrompittayarat W.; Okonogi S.; Kwankhao P.
(MDPI, 2022)
L-dopa, a dopaminergic agonist, is the gold standard for the treatment of Parkinson’s disease. However, due to the long-term toxicity and adverse effects of using L-dopa as the first-line therapy for Parkinson’s disease, ...